These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 10728764)

  • 1. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
    Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
    Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
    Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
    Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
    Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
    López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
    J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
    Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
    Costa M; Gameiro Silva MB; Silva JA; Skare TL
    Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum and clinical significance of autoantibodies against transfer RNA.
    Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
    Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.